Topotecan 1 mg/mL (Topotecan INJECTION, SOLUTION, CONCENTRATE) 1 mg/mL

Topotecan 1 mg/mL is an injectable solution used for specific medical treatments. This single-dose vial is manufactured by Hospira, Inc. in the USA.

Strength

1 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0302-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Topotecan 1 mg/mL is primarily used in intravenous therapy for certain types of cancer. It is often prescribed for conditions where targeted treatment is necessary. Patients and healthcare providers commonly seek information on what Topotecan is used for, particularly in advanced cancer care.

Side Effects

Topotecan 1 mg/mL may cause various effects, including nausea, fatigue, and changes in blood cell counts. Patients should discuss potential side effects with their healthcare provider to understand how this medication may affect them.

Precautions & Warnings

Handling Topotecan 1 mg/mL requires careful attention to dosage and administration guidelines. It is important to follow the instructions provided by a healthcare professional to ensure safe use. Proper storage and disposal are also crucial.

Avoid Interactions

Topotecan 1 mg/mL may interact with other medications, including certain chemotherapy drugs and supplements. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

Topotecan 1 mg/mL is used in intravenous therapy for certain types of cancer.

Topotecan 1 mg/mL is administered intravenously by a healthcare professional.

Common side effects may include nausea, fatigue, and changes in blood cell counts.

Patients should consult their healthcare provider before using Topotecan 1 mg/mL with other medications.

Topotecan 1 mg/mL should be stored according to the instructions provided by the manufacturer.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.